http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 김재찬.In Gul Lee. M.D.. Jae Chan Kim. M.D.. Ph.D. (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
이인걸,김재찬.In Gul Lee. M.D.. Jae Chan Kim. M.D.. Ph.D. 대한안과학회 2005 대한안과학회지 Vol.46 No.2
Purpose: Retinal neovascularization in diabetes has been thought to follow the release of local angiogenic factors in the retina. We hypothesized that neovascularization of diabetic retinopathy is a systemic vasculogenesis rather than a local angiogenesis. Thus, we evaluated the concentrations of circulating endothelial progenitor cells (EPCs) and stem cell modulation factors such as vascular endothelial growth factor (VEGF), erythropoietin (EPO), and substance p (SP) in the peripheral blood of diabetic retinopathy patients. Methods: We studied 15 normal controls and 45 Type 2 diabetic patients [non-DR group (n=15), NPDR group (n=15), and PDR group (n=15)]. We measured circulating CD34+mononuclear cells (CD34+MNCs) and c-Kit+ mononuclear cells (c-Kit+MNCs) by flow cytometry. VEGF, EPO and SP in the peripheral blood were measured by ELISA. Results: The circulating CD34+MNCs and c-Kit+MNCs increased in the NPDR and PDR groups compared with the control group (P<0.01). The serum level of VEGF was increased in the NPDR and PDR groups compared with the control group (P<0.05). The level of EPO was exclusively elevated in the non-DR group compared with the other three groups (P<0.01). The circulating SP level increased in the NPDR and PDR groups compared with the control group (P<0.05). Conclusions: The present study is the first to demonstrate that CD34+MNCs, c-Kit+MNCs and their modulator are elevated in diabetic retinopathy patients. Therefore, it is possible that circulating EPCs and serum VEGF, EPO and SP may be involved in the progression of diabetic retinopathy.
KCI
스콜라연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
